L322-0091 Screening compound: N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-methylpropanamide

L322-0091 Screening compound: N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-methylpropanamide
L322-0091 Screening compound: N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-methylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L322-0091
N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-methylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L322-0091

Molecular Formula

C19H27N3O4S (C19 H27 N3 O4 S)

Compound Name

N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-methylpropanamide

IUPAC name

N-[6-(cyclohexanesulfonyl)-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]-2-methylpropanamide

SMILES

CC(C)C(Nc(cc(c(N1C)c2)N(C)C1=O)c2S(C1CCCCC1)(=O)=O)=O

InChI

InChI=1S/C19H27N3O4S/c1-12(2)18(23)20-14-10-15-16(22(4)19(24)21(15)3)11-17(14)27(25,26)13-8-6-5-7-9-13/h10-13H,5-9H2,1-4H3,(H,20,23)

InChI Key

JKJWWIWHHJEHFU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244830

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.394

Distribution Coefficient, logD

3.393

Water Solubility, LogSw

-3.96

Polar Surface Area

70.281

Acid Dissociation Constant (pKa)

9.96

Base Dissociation Constant (pKb)

-1.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.90

L322-0091 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L322-0091 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L322-0091?
Check Price and Availability of L322-0091, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L322-0091 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L322-0091
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L322-0091
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L322-0091 available by request